1. Home
  2. RCS vs FOCL Comparison

RCS vs FOCL Comparison

Compare RCS & FOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PIMCO Strategic Income Fund Inc.

RCS

PIMCO Strategic Income Fund Inc.

HOLD

Current Price

$5.28

Market Cap

246.0M

Sector

Finance

ML Signal

HOLD

Logo EDAP TMS S.A. American Depositary Shares

FOCL

EDAP TMS S.A. American Depositary Shares

N/A

Current Price

$6.11

Market Cap

203.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RCS
FOCL
Founded
1994
N/A
Country
United States
France
Employees
N/A
289
Industry
Investment Managers
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
246.0M
203.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RCS
FOCL
Price
$5.28
$6.11
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
123.5K
61.0K
Earning Date
01-01-0001
N/A
Dividend Yield
10.12%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.09
$4.76
52 Week High
$8.00
$6.40

Technical Indicators

Market Signals
Indicator
RCS
FOCL
Relative Strength Index (RSI) 51.61 61.36
Support Level $5.10 $5.95
Resistance Level $5.36 $6.40
Average True Range (ATR) 0.10 0.27
MACD 0.02 -0.02
Stochastic Oscillator 69.23 62.82

Price Performance

Historical Comparison
RCS
FOCL

About RCS PIMCO Strategic Income Fund Inc.

PIMCO Strategic Income Fund, Inc. operates as a closed-end management investment company. Its primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities. The Fund also seeks capital appreciation to the extent consistent with the objective.

About FOCL EDAP TMS S.A. American Depositary Shares

Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.

Share on Social Networks: